234 related articles for article (PubMed ID: 21326023)
1. Retrospective comparison of diabetic foot ulcer and venous stasis ulcer healing outcome between a dermal repair scaffold (PriMatrix) and a bilayered living cell therapy (Apligraf).
Karr JC
Adv Skin Wound Care; 2011 Mar; 24(3):119-25. PubMed ID: 21326023
[TBL] [Abstract][Full Text] [Related]
2. Utilization of living bilayered cell therapy (Apligraf) for heel ulcers.
Karr J
Adv Skin Wound Care; 2008 Jun; 21(6):270-4. PubMed ID: 18525250
[TBL] [Abstract][Full Text] [Related]
3. Best-practice algorithms for the use of a bilayered living cell therapy (Apligraf) in the treatment of lower-extremity ulcers.
Cavorsi J; Vicari F; Wirthlin DJ; Ennis W; Kirsner R; O'Connell SM; Steinberg J; Falanga V
Wound Repair Regen; 2006; 14(2):102-9. PubMed ID: 16630097
[TBL] [Abstract][Full Text] [Related]
4. Apligraf in the treatment of neuropathic diabetic foot ulcers.
Edmonds M;
Int J Low Extrem Wounds; 2009 Mar; 8(1):11-8. PubMed ID: 19189997
[TBL] [Abstract][Full Text] [Related]
5. Innovative therapies in wound healing.
Shen JT; Falanga V
J Cutan Med Surg; 2003; 7(3):217-24. PubMed ID: 12704530
[TBL] [Abstract][Full Text] [Related]
6. Influence of bioengineered skin substitutes on diabetic foot ulcer and venous leg ulcer outcomes.
Barber C; Watt A; Pham C; Humphreys K; Penington A; Mutimer K; Edwards M; Maddern G
J Wound Care; 2008 Dec; 17(12):517-27. PubMed ID: 19052516
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Apligraf persistence and basement membrane restoration in donor site wounds: a pilot study.
Hu S; Kirsner RS; Falanga V; Phillips T; Eaglstein WH
Wound Repair Regen; 2006; 14(4):427-33. PubMed ID: 16939570
[TBL] [Abstract][Full Text] [Related]
8. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.
Curran MP; Plosker GL
BioDrugs; 2002; 16(6):439-55. PubMed ID: 12463767
[TBL] [Abstract][Full Text] [Related]
9. Experience with the use of apligraf to heal complicated surgical and nonsurgical wounds in a private practice setting.
Shealy FG; DeLoach ED
Adv Skin Wound Care; 2006; 19(6):310-22. PubMed ID: 16885645
[TBL] [Abstract][Full Text] [Related]
10. [Wound healing in venous ulcers; mechanisms, approach and modern developments].
Gibbs S; van den Hoogenband HM; de Boer EM
Ned Tijdschr Geneeskd; 2007 Mar; 151(11):635-40. PubMed ID: 17441566
[TBL] [Abstract][Full Text] [Related]
11. Tissue engineering in wound repair.
Falanga VJ
Adv Skin Wound Care; 2000; 13(2 Suppl):15-9. PubMed ID: 11074998
[TBL] [Abstract][Full Text] [Related]
12. Apligraf living skin equivalent for healing venous and chronic wounds.
Sibbald RG
J Cutan Med Surg; 1998 Dec; 3 Suppl 1():S1-24-8. PubMed ID: 10082604
[No Abstract] [Full Text] [Related]
13. Wound bed score and its correlation with healing of chronic wounds.
Falanga V; Saap LJ; Ozonoff A
Dermatol Ther; 2006; 19(6):383-90. PubMed ID: 17199681
[TBL] [Abstract][Full Text] [Related]
14. The role of Apligraf in the treatment of venous leg ulcers.
Dolynchuk K; Hull P; Guenther L; Sibbald RG; Brassard A; Cooling M; Delorme L; Gulliver W; Bourassa DH; Ho V; Kunimoto B; Overholt T; Papp K; Tousignant J
Ostomy Wound Manage; 1999 Jan; 45(1):34-43. PubMed ID: 10085970
[TBL] [Abstract][Full Text] [Related]
15. Tissue engineered skin: Apligraf, a bi-layered living skin equivalent.
Trent JF; Kirsner RS
Int J Clin Pract; 1998 Sep; 52(6):408-13. PubMed ID: 9894378
[TBL] [Abstract][Full Text] [Related]
16. Healing of elderly patients with diabetic foot ulcers, venous stasis ulcers, and pressure ulcers.
Brem H; Tomic-Canic M; Tarnovskaya A; Ehrlich HP; Baskin-Bey E; Gill K; Carasa M; Weinberger S; Entero H; Vladeck B
Surg Technol Int; 2003; 11():161-7. PubMed ID: 12931298
[TBL] [Abstract][Full Text] [Related]
17. Use of an acellular flowable dermal replacement scaffold on lower extremity sinus tract wounds: a retrospective series.
Brigido SA; Schwartz E; McCarroll R; Hardin-Young J
Foot Ankle Spec; 2009 Apr; 2(2):67-72. PubMed ID: 19825754
[TBL] [Abstract][Full Text] [Related]
18. Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers.
Langer A; Rogowski W
BMC Health Serv Res; 2009 Jul; 9():115. PubMed ID: 19591680
[TBL] [Abstract][Full Text] [Related]
19. The role of graftskin (Apligraf) in difficult-to-heal venous leg ulcers.
Bello YM; Falabella AF
J Wound Care; 2002 May; 11(5):182-3. PubMed ID: 12055943
[TBL] [Abstract][Full Text] [Related]
20. [Ulcus cruris and other problem cases. How suppurative wounds heal].
Neumaier J
MMW Fortschr Med; 2004 Feb; 146(6):4-6. PubMed ID: 15035302
[No Abstract] [Full Text] [Related]
[Next] [New Search]
